399 related articles for article (PubMed ID: 36359286)
1. The Role of Epigenetics in the Development and Progression of Multiple Myeloma.
Ismail NH; Mussa A; Zakaria NA; Al-Khreisat MJ; Zahidin MA; Ramli NN; Mohammad SNNA; Hassan R; Mohd Noor NH; Iberahim S; Zulkafli Z; Mohamed Yusoff S; Husin A; Johan MF
Biomedicines; 2022 Oct; 10(11):. PubMed ID: 36359286
[TBL] [Abstract][Full Text] [Related]
2. Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity?
Muylaert C; Van Hemelrijck LA; Maes A; De Veirman K; Menu E; Vanderkerken K; De Bruyne E
Front Oncol; 2022; 12():979569. PubMed ID: 36059621
[TBL] [Abstract][Full Text] [Related]
3. Investigating the Interplay between Myeloma Cells and Bone Marrow Stromal Cells in the Development of Drug Resistance: Dissecting the Role of Epigenetic Modifications.
Schütt J; Nägler T; Schenk T; Brioli A
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439223
[TBL] [Abstract][Full Text] [Related]
4. Epigenetics in multiple myeloma: From mechanisms to therapy.
Alzrigat M; Párraga AA; Jernberg-Wiklund H
Semin Cancer Biol; 2018 Aug; 51():101-115. PubMed ID: 28962927
[TBL] [Abstract][Full Text] [Related]
5. Drug resistance in multiple myeloma.
Robak P; Drozdz I; Szemraj J; Robak T
Cancer Treat Rev; 2018 Nov; 70():199-208. PubMed ID: 30245231
[TBL] [Abstract][Full Text] [Related]
6. Proteomic Alteration in the Progression of Multiple Myeloma: A Comprehensive Review.
Ismail NH; Mussa A; Al-Khreisat MJ; Mohamed Yusoff S; Husin A; Johan MF
Diagnostics (Basel); 2023 Jul; 13(14):. PubMed ID: 37510072
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic Aberrations in Multiple Myeloma.
Caprio C; Sacco A; Giustini V; Roccaro AM
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33076518
[TBL] [Abstract][Full Text] [Related]
8. The Epigenome in Multiple Myeloma: Impact on Tumor Cell Plasticity and Drug Response.
De Smedt E; Lui H; Maes K; De Veirman K; Menu E; Vanderkerken K; De Bruyne E
Front Oncol; 2018; 8():566. PubMed ID: 30619733
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation.
Amodio N; D'Aquila P; Passarino G; Tassone P; Bellizzi D
Expert Opin Ther Targets; 2017 Jan; 21(1):91-101. PubMed ID: 27892767
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in epigenetic anticancer therapeutics and future perspectives.
Ren L; Yang Y; Li W; Yang H; Zhang Y; Ge B; Zhang S; Du G; Wang J
Front Genet; 2022; 13():1085391. PubMed ID: 36685834
[TBL] [Abstract][Full Text] [Related]
11. Multiple Myeloma: Molecular Pathogenesis and Disease Evolution.
Heider M; Nickel K; Högner M; Bassermann F
Oncol Res Treat; 2021; 44(12):672-681. PubMed ID: 34749378
[TBL] [Abstract][Full Text] [Related]
12. The Role of N
Zhao Y; Peng H
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053496
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics: Recent Advances and Its Role in the Treatment of Alzheimer's Disease.
Xiao X; Liu X; Jiao B
Front Neurol; 2020; 11():538301. PubMed ID: 33178099
[No Abstract] [Full Text] [Related]
14. [Role of Biology Based on Epigenetics in Multiple Myeloma].
Wang BB; Wu T
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):939-44. PubMed ID: 27342538
[TBL] [Abstract][Full Text] [Related]
15. [The epigenetic alteration and the effect of HDAC inhibitors in multiple myeloma].
Terui Y
Nihon Rinsho; 2015 Jan; 73(1):124-9. PubMed ID: 25626317
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Crosstalk between Malignant Plasma Cells and the Tumour Microenvironment in Multiple Myeloma.
Allegra A; Casciaro M; Barone P; Musolino C; Gangemi S
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681577
[TBL] [Abstract][Full Text] [Related]
17. [Epigenetics of schizophrenia: a review].
Rivollier F; Lotersztajn L; Chaumette B; Krebs MO; Kebir O
Encephale; 2014 Oct; 40(5):380-6. PubMed ID: 25127897
[TBL] [Abstract][Full Text] [Related]
18. The potential role of epigenetic therapy in multiple myeloma.
Smith EM; Boyd K; Davies FE
Br J Haematol; 2010 Mar; 148(5):702-13. PubMed ID: 19912222
[TBL] [Abstract][Full Text] [Related]
19. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
Chung C
Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
[TBL] [Abstract][Full Text] [Related]
20. The Multiple Myeloma Landscape: Epigenetics and Non-Coding RNAs.
Coira IF; Rincón R; Cuendet M
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35625953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
